The New Drug Evaluation for oral semaglutide (Rybelsus) for the treatment of type 2 diabetes mellitus is now available to stakeholders.
News
14th Oct 2020
Our October 2020 Monthly Horizon Scanning Report is now available.
13th Oct 2020
Updates to our Items not to be routinely prescribed (INRP) report with 20202021 Q1 data are now available online.
12th Oct 2020
The antibacterial drugs report for April to June 2020 is now available.
9th Oct 2020
The New Drug Evaluation for Brolucizumab for the treatment of wet age-related macular degeneration is now available to stakeholders.
8th Oct 2020
The latest NCSO bulletin based on September 2020 prices is now available online for stakeholders only.
7th Oct 2020
The RDTC has updated the COVID-19 QAAs No.7 (Electronic repeat dispensing advice ), and No.
5th Oct 2020
Updates to our Cardiovascular, Dementia, Diabetes and Respiratory reports with 2020/2021 Q1 data are now available online.
1st Oct 2020
The RDTC has updated COVID-19 QAA No 13 (Anticoagulation in cancer) with minor changes to the weblinks.
29th Sep 2020
The RDTC has updated the COVID-19 QAAs No.5 (Prescribing in diabetes guidance), and No.
Pages
